>> Sponsored Symposia GSK

Print PDF
Wednesday, July 7, 2010
12:30-14:00

Lunch Symposium organized by GlaxoSmithKline Biologicals


BECAUSE CERVICAL CANCER PREVENTION MATTERS


Chairs:
Prof. Eduardo Franco, Division of Cancer Epidemiology, McGill University, Montreal, Canada
Dr. Hugues Bogaerts, GlaxoSmithKline Biologicals, Belgium

Welcome and introduction

Prof. Eduardo Franco, Division of Cancer Epidemiology, McGill University, Montreal, QC, Canada

Cervical cancer vaccination:
A compelling case

Dr. Swee Chong Quek, Department of Gynaecological Oncology, KK Women’s & Children’s Hospital, Singapore

Immunology of HPV infection: Implications for vaccine development

Prof. Lutz Gissman, German Cancer Research Center, Heidelberg, Germany

Cervical cancer vaccination:
Clinical outcomes with Cervarix®

Prof. Fred Aoki, Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada

All about preventing more cervical cancers

Prof. Jack Cuzick, UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, United Kingdom

 

Learning Objectives:
  • To increase awareness of cervical cancer and the need for the most extensive prevention possible
  • To discuss the development vision of Cervarix and give an update on the latest clinical data from pivotal phase II and III trials
  • To discuss the value of vaccination and screening in cervical cancer prevention
  • To discuss the population impact that can be expected from primary and secondary prevention of cervical cancer in a real world setting